Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery during Antiplatelet Therapy?

Circulation

Volumn 138, Issue 19, 2018, Pages 2145-2159

  Mahla, Elisabeth ^a   Tantry, Udaya S ^b   Prüller, Florian ^a   Gurbel, Paul A ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b INOVA HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

cardiac surgical procedures; hemorrhage; platelet aggregation inhibitors; platelet function tests; purinergic P2Y12 receptor antagonists

Indexed keywords

FIBRINOGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IIB; HEPARIN; PURINERGIC P2Y12 RECEPTOR; THROMBIN; THROMBOPLASTIN; TIROFIBAN; WARFARIN; ANTITHROMBOCYTIC AGENT; P2RY12 PROTEIN, HUMAN; PURINERGIC P2Y RECEPTOR ANTAGONIST;

ACUTE CORONARY SYNDROME; ACUTE LUNG INJURY; ANTIPLATELET ACTIVITY; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DUAL ANTIPLATELET THERAPY; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; OPERATIVE BLOOD LOSS; PERCUTANEOUS CORONARY INTERVENTION; PHARMACODYNAMICS; PLATELET COUNT; PLATELET REACTIVITY; PRIORITY JOURNAL; STENT THROMBOSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; THROMBOELASTOMETRY; ADVERSE EVENT; BLOOD; BLOOD CLOTTING PARAMETERS; COMBINATION DRUG THERAPY; DRUG ADMINISTRATION; DRUG EFFECT; DRUG MONITORING; METABOLISM; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE; PREOPERATIVE CARE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE; TREATMENT OUTCOME;

BLOOD LOSS, SURGICAL; BLOOD PLATELETS; CARDIAC SURGICAL PROCEDURES; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; DRUG THERAPY, COMBINATION; HUMANS; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 85057106752     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.118.035160     Document Type: Article

References (88)

1. Held C, Asenblad N, Bassand JP, Becker RC, Cannon CP, Claeys MJ, Harrington RA, Horrow J, Husted S, James SK, Mahaffey KW, Nicolau JC, Scirica BM, Storey RF, Vintila M, Ycas J, Wallentin L, Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 2011 57 672 684. doi: 10.1016/j.jacc.2010.10.029
2. Masoudi FA, Ponirakis A, Yeh RW, Maddox TM, Beachy J, Casale PN, Curtis JP, De Lemos J, Fonarow G, Heidenreich P, Koutras C, Kremers M, Messenger J, Moussa I, Oetgen WJ, Roe MT, Rosenfield K, Shields TP Jr, Spertus JA, Wei J, White C, Young CH, Rumsfeld JS, Cardiovascular care facts: a report from the national cardiovascular data registry: 2011. J Am Coll Cardiol 2013 62 1931 1947. doi: 10.1016/j.jacc.2013.05.099
3. Smith PK, Goodnough LT, Levy JH, Poston RS, Short MA, Weerakkody GJ, Lenarz LA, Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. J Am Coll Cardiol 2012 60 388 396. doi: 10.1016/j.jacc.2012.03.030
4. Hall R, Mazer CD, Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg 2011 112 292 318. doi: 10.1213/ANE.0b013e318203f38d
5. Essebag V, Verma A, Healey JS, Krahn AD, Kalfon E, Coutu B, Ayala-Paredes F, Tang AS, Sapp J, Sturmer M, Keren A, Wells GA, Birnie DH, BRUISE CONTROL Investigators Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION Study. J Am Coll Cardiol 2016 67 1300 1308. doi: 10.1016/j.jacc.2016.01.009
6. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, Fukushima J, Kalil Filho R, Sierra DB, Lopes NH, Mauad T, Roquim AC, Sundin MR, Leão WC, Almeida JP, Pomerantzeff PM, Dallan LO, Jatene FB, Stolf NA, Auler JO Jr, Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010 304 1559 1567. doi: 10.1001/jama.2010.1446
7. Kamel H, Johnston SC, Kirkham JC, Turner CG, Kizer JR, Devereux RB, Iadecola C, Association between major perioperative hemorrhage and stroke or Q-wave myocardial infarction. Circulation 2012 126 207 212. doi: 10.1161/CIRCULATIONAHA.112.094326
8. Mehta RH, Sheng S, O'Brien SM, Grover FL, Gammie JS, Ferguson TB, Peterson ED, Society of Thoracic Surgeons National Cardiac Surgery Database I Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes 2009 2 583 590.
9. Hansson EC, Jidéus L, Åberg B, Bjursten H, Dreifaldt M, Holmgren A, Ivert T, Nozohoor S, Barbu M, Svedjeholm R, Jeppsson A, Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J 2016 37 189 197. doi: 10.1093/eurheartj/ehv381
10. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD, Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007 116 2544 2552. doi: 10.1161/CIRCULATIONAHA.107.698977
11. Généreux P, Giustino G, Witzenbichler B, Weisz G, Stuckey TD, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri E, Yadav M, Francese DP, Palmerini T, Kirtane AJ, Litherland C, Mehran R, Stone GW, Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention. J Am Coll Cardiol 2015 66 1036 1045. doi: 10.1016/j.jacc.2015.06.1323
12. Spahn DR, Goodnough LT, Alternatives to blood transfusion. Lancet 2013 381 1855 1865. doi: 10.1016/S0140-6736(13)60808-9
13. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ, 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2014 130 2354 2394.
14. Boer C, Meesters MI, Milojevic M, Benedetto U, Bolliger D, von Heymann C, Jeppsson A, Koster A, Osnabrugge RL, Ranucci M, Ravn HB, Vonk ABA, Wahba A, Pagano D, 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth 2018 32 88 120.
15. Ferraris VA, Saha SP, Oestreich JH, Song HK, Rosengart T, Reece TB, Mazer CD, Bridges CR, Despotis GJ, Jointer K, Clough ER, Society of Thoracic Surgeons 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 2012 94 1761 1781. doi: 10.1016/j.athoracsur.2012.07.086
16. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN, ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018 39 213 260. doi: 10.1093/eurheartj/ehx419
17. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM, Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003 107 2908 2913. doi: 10.1161/01.CIR.0000072771.11429.83
18. Malm CJ, Hansson EC, Åkesson J, Andersson M, Hesse C, Shams Hakimi C, Jeppsson A, Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study. Br J Anaesth 2016 117 309 315. doi: 10.1093/bja/aew189
19. Price MJ, Walder JS, Baker BA, Heiselman DE, Jakubowski JA, Logan DK, Winters KJ, Li W, Angiolillo DJ, Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial. J Am Coll Cardiol 2012 59 2338 2343. doi: 10.1016/j.jacc.2012.02.042
20. Gurbel PA, Bliden KP, Butler K, Tantry US, Gesheff T, Wei C, Teng R, Antonino MJ, Patil SB, Karunakaran A, Kereiakes DJ, Parris C, Purdy D, Wilson V, Ledley GS, Storey RF, Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009 120 2577 2585. doi: 10.1161/CIRCULATIONAHA.109.912550
21. Ebrahimi R, Dyke C, Mehran R, Manoukian SV, Feit F, Cox DA, Gersh BJ, Ohman EM, White HD, Moses JW, Ware JH, Lincoff AM, Stone GW, Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 2009 53 1965 1972. doi: 10.1016/j.jacc.2009.03.006
22. Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J, Kirtane A, Siller-Matula J, Mahla E, Becker RC, Bhatt DL, Waksman R, Rao SV, Alexopoulos D, Marcucci R, Reny JL, Trenk D, Sibbing D, Gurbel PA, Working Group on On-Treatment Platelet Reactivity Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 2013 62 2261 2273. doi: 10.1016/j.jacc.2013.07.101
23. Mahla E, Metzler H, Tantry US, Gurbel PA, Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery. Ann Thorac Surg 2010 90 1040 1051. doi: 10.1016/j.athoracsur.2010.04.041
24. Hoffman M, Dargaud Y, Mechanisms and monitoring of bypassing agent therapy. J Thromb Haemost 2012 10 1478 1485. doi: 10.1111/j.1538-7836.2012.04793.x
25. Ruggeri ZM, Platelets in atherothrombosis. Nat Med 2002 8 1227 1234. doi: 10.1038/nm1102-1227
26. Gurbel PA, Tantry US, Platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents. Circulation 2012 125 1276 1287.
27. Kirtane AJ, Parikh PB, Stuckey TD, Xu K, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL Jr, Parvataneni R, Maehara A, Généreux P, Mehran R, Stone GW, Is there an ideal level of platelet P2Y12-receptor inhibition in patients undergoing percutaneous coronary intervention?: "Window" analysis from the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). JACC Cardiovasc Interv 2015 8 1978 1987. doi: 10.1016/j.jcin.2015.08.032
28. Aradi D, Kirtane A, Bonello L, Gurbel PA, Tantry US, Huber K, Freynhofer MK, ten Berg J, Janssen P, Angiolillo DJ, Siller-Matula JM, Marcucci R, Patti G, Mangiacapra F, Valgimigli M, Morel O, Palmerini T, Price MJ, Cuisset T, Kastrati A, Stone GW, Sibbing D, Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur Heart J 2015 36 1762 1771. doi: 10.1093/eurheartj/ehv104
29. Mahla E, Suarez TA, Bliden KP, Rehak P, Metzler H, Sequeira AJ, Cho P, Sell J, Fan J, Antonino MJ, Tantry US, Gurbel PA, Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 2012 5 261 269. doi: 10.1161/CIRCINTERVENTIONS.111.967208
30. Mannacio V, Meier P, Antignano A, Di Tommaso L, De Amicis V, Vosa C, Individualized strategy for clopidogrel suspension in patients undergoing off-pump coronary surgery for acute coronary syndrome: a case-control study. J Thorac Cardiovasc Surg 2014 148 1299 1306. doi: 10.1016/j.jtcvs.2013.12.011
31. Tantry US, Mahla E, Gesheff MG, Gurbel PA, Importance of measurement of platelet reactivity to ADP in patients with coronary artery disease: an historical account. Expert Rev Cardiovasc Ther 2013 11 1547 1556. doi: 10.1586/14779072.2013.839382
32. Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schömig A, Kastrati A, von Beckerath N, Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008 99 121 126. doi: 10.1160/TH07-07-0478
33. Price MJ, Bedside evaluation of thienopyridine antiplatelet therapy. Circulation 2009 119 2625 2632. doi: 10.1161/CIRCULATIONAHA.107.696732
34. Gurbel PA, Bliden KP, Tantry US, Monroe AL, Muresan AA, Brunner NE, Lopez-Espina CG, Delmenico PR, Cohen E, Raviv G, Haugen DL, Ereth MH, First report of the point-of-care TEG: A technical validation study of the TEG-6S system. Platelets 2016 27 642 649. doi: 10.3109/09537104.2016.1153617
35. Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG, A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007 28 1702 1708. doi: 10.1093/eurheartj/ehm226
36. Grove EL, Hvas AM, Johnsen HL, Hedegaard SS, Pedersen SB, Mortensen J, Kristensen SD, A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease. Thromb Haemost 2010 103 1245 1253. doi: 10.1160/TH09-08-0527
37. Tsantes A, Ikonomidis I, Papadakis I, Kottaridi C, Tsante A, Kalamara E, Kardoulaki A, Kopterides P, Kapsimali V, Karakitsos P, Lekakis J, Travlou A, Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance. Platelets 2012 23 481 489. doi: 10.3109/09537104.2012.689037
38. Gurbel PA, Bliden KP, Zaman KA, Yoho JA, Hayes KM, Tantry US, Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. Circulation 2005 111 1153 1159. doi: 10.1161/01.CIR.0000157138.02645.11
39. Matetzky S, Shenkman B, Guetta V, Shechter M, Beinart R, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, Hod H, Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004 109 3171 3175. doi: 10.1161/01.CIR.0000130846.46168.03
40. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009 150 396 404.
41. Mangano DT, Multicenter Study of Perioperative Ischemia Research Group Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002 347 1309 1317. doi: 10.1056/NEJMoa020798
42. Lim E, Ali Z, Ali A, Routledge T, Edmonds L, Altman DG, Large S, Indirect comparison meta-analysis of aspirin therapy after coronary surgery. BMJ 2003 327 1309. doi: 10.1136/bmj.327.7427.1309
43. Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US, Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation 2007 115 3156 3164. doi: 10.1161/CIRCULATIONAHA.106.675587
44. Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, Testa L, Sheiban I, Sangiorgi G, A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006 27 2667 2674. doi: 10.1093/eurheartj/ehl334
45. Hastings S, Myles P, McIlroy D, Aspirin and coronary artery surgery: a systematic review and meta-analysis. Br J Anaesth 2015 115 376 385. doi: 10.1093/bja/aev164
46. Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network Stopping vs. continuing aspirin before coronary artery surgery. N Engl J Med 2016 374 728 737. doi: 10.1056/NEJMoa1507688
47. Weber CF, Görlinger K, Byhahn C, Moritz A, Hanke AA, Zacharowski K, Meininger D, Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy. Eur J Anaesthesiol 2011 28 57 62. doi: 10.1097/EJA.0b013e32834050ab
48. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM, TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007 357 2001 2015. doi: 10.1056/NEJMoa0706482
49. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsén M, PLATO Investigators Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009 361 1045 1057. doi: 10.1056/NEJMoa0904327
50. Biancari F, Airaksinen KE, Lip GY, Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies. J Thorac Cardiovasc Surg 2012 143 665 675.e4. doi: 10.1016/j.jtcvs.2011.01.069
51. Morici N, Moja L, Rosato V, Oreglia JA, Sacco A, De Marco F, Bruschi G, Klugmann S, La Vecchia C, Savonitto S, Time from adenosine di-phosphate receptor antagonist discontinuation to coronary bypass surgery in patients with acute coronary syndrome: meta-analysis and meta-regression. Int J Cardiol 2013 168 1955 1964. doi: 10.1016/j.ijcard.2012.12.087
52. Nijjer SS, Watson G, Athanasiou T, Malik IS, Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies. Eur Heart J 2011 32 2970 2988. doi: 10.1093/eurheartj/ehr151
53. Siller-Matula JM, Petre A, Delle-Karth G, Huber K, Ay C, Lordkipanidzé M, De Caterina R, Kolh P, Mahla E, Gersh BJ, Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 2017 6 753 770. doi: 10.1177/2048872615585516
54. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Katus HA, Apple FS, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Gabriel Steg P, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR, Third universal definition of myocardial infarction. Eur Heart J 2012 32 2551 2567.
55. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H, Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011 123 2736 2747. doi: 10.1161/CIRCULATIONAHA.110.009449
56. Chowdhury M, Shore-Lesserson L, Mais AM, Leyvi G, Thromboelastograph with Platelet Mapping™ predicts postoperative chest tube drainage in patients undergoing coronary artery bypass grafting. J Cardiothorac Vasc Anesth 2014 28 217 223. doi: 10.1053/j.jvca.2013.12.010
57. Della Corte A, Bancone C, Spadafora A, Borrelli M, Galdieri N, Quintiliano SN, Bifulco O, De Feo M, Postoperative bleeding in coronary artery bypass patients on double antiplatelet therapy: predictive value of preoperative aggregometry. Eur J Cardiothorac Surg 2017 52 901 908. doi: 10.1093/ejcts/ezx181
58. Kwak YL, Kim JC, Choi YS, Yoo KJ, Song Y, Shim JK, Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery. J Am Coll Cardiol 2010 56 1994 2002. doi: 10.1016/j.jacc.2010.03.108
59. Mahla E, Prueller F, Farzi S, Pregartner G, Raggam RB, Beran E, Toller W, Berghold A, Tantry US, Gurbel PA, Does platelet reactivity predict bleeding in patients needing urgent coronary artery bypass grafting during dual antiplatelet therapy? Ann Thorac Surg 2016 102 2010 2017. doi: 10.1016/j.athoracsur.2016.05.003
60. Plicner D, Mazur P, Hymczak H, Stoliński J, Litwinowicz R, Drwiła R, Undas A, Preoperative platelet aggregation predicts perioperative blood loss and rethoracotomy for bleeding in patients receiving dual antiplatelet treatment prior to coronary surgery. Thromb Res 2015 136 519 525. doi: 10.1016/j.thromres.2015.04.037
61. Ranucci M, Baryshnikova E, Soro G, Ballotta A, De Benedetti D, Conti D, Surgical and Clinical Outcome Research (SCORE) Group Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg 2011 91 123 129. doi: 10.1016/j.athoracsur.2010.09.022
62. Ranucci M, Colella D, Baryshnikova E, Di Dedda U, Surgical and Clinical Outcome Research (SCORE) Group Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery. Br J Anaesth 2014 113 970 976. doi: 10.1093/bja/aeu315
63. Rosengart TK, Romeiser JL, White LJ, Fratello A, Fallon E, Senzel L, Shroyer AL, Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration. J Thorac Cardiovasc Surg 2013 146 1259 1266, 1266.e1; discussion 1266. doi: 10.1016/j.jtcvs.2013.06.029
64. Kasivisvanathan R, Abbassi-Ghadi N, Kumar S, Mackenzie H, Thompson K, James K, Mallett SV, Risk of bleeding and adverse outcomes predicted by thromboelastography platelet mapping in patients taking clopidogrel within 7 days of non-cardiac surgery. Br J Surg 2014 101 1383 1390. doi: 10.1002/bjs.9592
65. Amour J, Garnier M, Szymezak J, Le Manach Y, Helley D, Bertil S, Ouattara A, Riou B, Gaussem P, Prospective observational study of the effect of dual antiplatelet therapy with tranexamic acid treatment on platelet function and bleeding after cardiac surgery. Br J Anaesth 2016 117 749 757. doi: 10.1093/bja/aew357
66. Dalén M, van der Linden J, Holm M, Lindvall G, Ivert T, Adenosine diphosphate-induced single-platelet count aggregation and bleeding in clopidogrel-treated patients undergoing coronary artery bypass grafting. J Cardiothorac Vasc Anesth 2014 28 230 234. doi: 10.1053/j.jvca.2013.10.007
67. Reed GW, Kumar A, Guo J, Aranki S, Shekar P, Agnihotri A, Maree AO, McLean DS, Rosenfield K, Cannon CP, Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: verify pre-op TIMI 45-a pilot study. Clin Cardiol 2015 38 92 98. doi: 10.1002/clc.22357
68. Dyke C, Aronson S, Dietrich W, Hofmann A, Karkouti K, Levi M, Murphy GJ, Sellke FW, Shore-Lesserson L, von Heymann C, Ranucci M, Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg 2014 147 1458 1463.e1. doi: 10.1016/j.jtcvs.2013.10.070
69. Gombotz H, Rehak PH, Shander A, Hofmann A, Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007 47 1468 1480. doi: 10.1111/j.1537-2995.2007.01286.x
70. Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, Bassi AK, Tantry US, Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 2005 46 1820 1826. doi: 10.1016/j.jacc.2005.07.041
71. Gurbel PA, Bliden KP, Navickas IA, Mahla E, Dichiara J, Suarez TA, Antonino MJ, Tantry US, Cohen E, Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events. Am Heart J 2010 160 346 354. doi: 10.1016/j.ahj.2010.05.034
72. Deppe AC, Weber C, Zimmermann J, Kuhn EW, Slottosch I, Liakopoulos OJ, Choi YH, Wahlers T, Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients. J Surg Res 2016 203 424 433. doi: 10.1016/j.jss.2016.03.008
73. Karkouti K, Callum J, Wijeysundera DN, Rao V, Crowther M, Grocott HP, Pinto R, Scales DC, TACS Investigators Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial. Circulation 2016 134 1152 1162. doi: 10.1161/CIRCULATIONAHA.116.023956
74. Serraino GF, Murphy GJ, Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: updated systematic review and meta-analysis. Br J Anaesth 2017 118 823 833. doi: 10.1093/bja/aex100
75. Agarwal S, Johnson RI, Shaw M, Preoperative point-of-care platelet function testing in cardiac surgery. J Cardiothorac Vasc Anesth 2015 29 333 341. doi: 10.1053/j.jvca.2014.06.025
76. Frank SM, Savage WJ, Rothschild JA, Rivers RJ, Ness PM, Paul SL, Ulatowski JA, Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology 2012 117 99 106. doi: 10.1097/ALN.0b013e318255e550
77. Shi J, Wang G, Lv H, Yuan S, Wang Y, Ji H, Li L, Tranexamic a cid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: randomized trial and 1-year follow-up. Ann Thorac Surg 2013 95 795 802. doi: 10.1016/j.athoracsur.2012.07.015
78. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014 35 2541 2619
79. Angiolillo DJ, Firstenberg MS, Price MJ, Tummala PE, Hutyra M, Welsby IJ, Voeltz MD, Chandna H, Ramaiah C, Brtko M, Cannon L, Dyke C, Liu T, Montalescot G, Manoukian SV, Prats J, Topol EJ, BRIDGE Investigators Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 2012 307 265 274. doi: 10.1001/jama.2011.2002
80. Capodanno D, Angiolillo DJ, Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation 2013 128 2785 2798. doi: 10.1161/CIRCULATIONAHA.113.003675
81. Savonitto S, Caracciolo M, Cattaneo M, DE Servi S, Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. J Thromb Haemost 2011 9 2133 2142. doi: 10.1111/j.1538-7836.2011.04456.x
82. Vilahur G, Choi BG, Zafar MU, Viles-Gonzalez JF, Vorchheimer DA, Fuster V, Badimon JJ, Normalization of platelet reactivity in clopidogrel-treated subjects. J Thromb Haemost 2007 5 82 90. doi: 10.1111/j.1538-7836.2006.02245.x
83. Zafar MU, Santos-Gallego C, Vorchheimer DA, Viles-Gonzalez JF, Elmariah S, Giannarelli C, Sartori S, Small DS, Jakubowski JA, Fuster V, Badimon JJ, Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation. J Thromb Haemost 2013 11 100 106. doi: 10.1111/jth.12058
84. Scharbert G, Wetzel L, Schrottmaier WC, Kral JB, Weber T, Assinger A, Comparison of patient intake of ticagrelor, prasugrel, or clopidogrel on restoring platelet function by donor platelets. Transfusion 2015 55 1320 1326. doi: 10.1111/trf.12977
85. Zafar MU, Smith DA, Baber U, Sartori S, Chen K, Lam DW, Linares-Koloffon CA, Rey-Mendoza J, Jimenez Britez G, Escolar G, Fuster V, Badimon JJ, Impact of timing on the functional recovery achieved with platelet supplementation after treatment with ticagrelor. Circ Cardiovasc Interv 2017 10: e005120. doi: 10.1161/CIRCINTERVENTIONS.117.005120
86. Teng R, Carlson GF, Nylander S, Andersson TL, Effects of autologous platelet transfusion on platelet inhibition in ticagrelor-treated and clopidogrel-treated subjects. J Thromb Haemost 2016 14 2342 2352. doi: 10.1111/jth.13511
87. Prüller F, Drexler C, Archan S, Macher S, Raggam RB, Mahla E, Low platelet reactivity is recovered by transfusion of stored platelets: a healthy volunteer in vivo study. J Thromb Haemost 2011 9 1670 1673. doi: 10.1111/j.1538-7836.2011.04392.x
88. O'Connor SA, Amour J, Mercadier A, Martin R, Kerneis M, Abtan J, Brugier D, Silvain J, Barthélémy O, Leprince P, Montalescot G, Collet JP, ACTION Study Group Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study. Circ Cardiovasc Interv 2015 8 e002786. doi: 10.1161/CIRCINTERVENTIONS.115.002786